Zimmer Biomet - Rasio total nilai perusahaan marang pendapatan ZBH

Zimmer Biomet Holdings, Inc. (ZBH) - logo korporat

Zimmer Biomet Holdings (ZBH) dominates the joint implant segment, leveraging the consistent demand of an aging population and a stable cash flow. The EV/Sales trend illustrates current price corridors, where the 3070.79 level captures the current state. Cost optimization via contract manufacturing accelerates the launch of new products, while expansion into robotic surgery and ambulatory centers extends its market influence.

Multiplikator EV/Sales Zimmer Biomet Corp (ZBH): kanggo periode 23.11.2025 - 20.11.2026

Rincian metrik keuangan lan pasar Zimmer Biomet Holdings, Inc. (ZBH)

- rega saham lan konsensus proyeksi valuasi:
- indikator dhuwit lan arus kas:
Pambiji fundamental perusahaan:ZBH, Zimmer Biomet Holdings
Barang unggulan Zimmer Biomet

EV/Sales (co) measures the total enterprise value of the business, including debt, relative to annual revenue, thereby excluding the impact of credit load on the valuation. For Zimmer Biomet Holdings (ZBH), this filter is critical, as revenue scalability is driven by installed equipment and consistent demand for proprietary implants. Analyzing the enterprise value-to-revenue ratio on GURU.Markets allows investors to promptly identify asset overvaluation or determine a safe entry point.

Analisis pesaing

BSX (Boston Scientific) - Rasio nilai perusahaan marang pendapatan|EW: Multiplikator EV/Sales|RMD - Rasio total nilai perusahaan marang pendapatan|PODD (Insulet Inc.) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan CooperVision (COO)|Multiplikator EV/Sales ALGN|Nilai perusahaan marang pendapatan Globus Medical, Inc. GMED|Multiplikator EV/Sales TMDX (transmedics.com)|Multiplikator EV/Sales Alphatec Holdings ATEC|AORT - Rasio nilai perusahaan marang pendapatan|ENOV: Rasio nilai perusahaan marang pendapatan|IART (Integra LifeSciences) - Nilai perusahaan marang pendapatan|Establishment Labs - Nilai bisnis marang pendapatan|BBNX (iLet Bionic Pancreas) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan IRADIMED Corp IRMD|Rasio nilai perusahaan marang pendapatan Embecta Corp (EMBC)|Tandem Diabetes Care (TNDM) - Rasio nilai perusahaan marang dodolan|Axogen Surgical - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales SI-BONE, Inc. SIBN|Orthofix Medical - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan BVS|OrthoPediatrics (KIDS) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan TMCI (Treace Corp)|Rasio nilai perusahaan marang pendapatan blade.com|Nilai perusahaan marang pendapatan Carlsmed Inc (CARL)|Multiplikator EV/Sales RXST|CLPT - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Stereotaxis, Inc. STXS|STIM: Rasio nilai perusahaan marang pendapatan|SGHT: Nilai perusahaan marang pendapatan|Orchestra BioMed Inc. - Koefisien nilai perusahaan marang pendapatan|ANIK: Multiplikator EV/Sales|NSPR - Rasio total nilai perusahaan marang pendapatan|ZJYL (Jin Medical) - Multiplikator EV/Sales|Vivani Medical (VANI) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales XTNT|Multiplikator EV/Sales n1mtc.com (NMTC)|Modular Medical Inc - Nilai perusahaan marang pendapatan|Myomo, Inc (MYO) - Multiplikator nilai perusahaan marang pendapatan|COCH: Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Vivos Therapeutics VVOS|enVVeno Medical Corp. (NVNO) - Rasio nilai perusahaan marang pendapatan|Sintx Technologies - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Tenon Medical Inc.|LFWD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales AMIX|Koefisien nilai perusahaan marang pendapatan IVF|Rasio nilai perusahaan marang pendapatan Bone Biologics BBLG|Rasio total nilai perusahaan marang pendapatan axonics.com (AXNX)|BIOL - Rasio nilai perusahaan marang pendapatan|Dynatronics (DYNT) - Nilai perusahaan marang pendapatan|Paragon 28, Inc. (FNA) - Rasio nilai perusahaan marang pendapatan|INVO - Rasio total nilai perusahaan marang pendapatan